Search results
Multiple omics levels of chronic lymphocytic leukemia - Cell Death Discovery
Nature· 3 days agoChronic lymphocytic leukemia (CLL) is a lymphoproliferative malignancy characterized by the proliferation of functionally mature but ...
Nurix Therapeutics, With 345% Run, Posts A 'Clear Win' In Leukemia Treatment
Investor's Business Daily· 6 days agoNurix Therapeutics posted a "clear win" in leukemia treatment on Monday, but the biotech stock gave...
EHA 2024: Brukinsa/Venclexta for CLL/SLL lacks control arm in SEQUOIA trial
Clinical Trials Arena via Yahoo Finance· 6 days agoCLL and SLL are among the most common haematological...BTK) inhibitors and B cell lymphoma 2 (BCL-2)...
Why Is Penny Stock Mustang Bio Trading Over 190% On Monday? - Mustang Bio (NASDAQ:MBIO)
Benzinga· 7 days agoMB-106 is being developed in a collaboration between Mustang and Fred Hutch Cancer Center to treat...
Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL
MedPage Today· 7 days agoA fixed-duration, three-drug regimen for chronic lymphocytic leukemia (CLL) achieved deep and...
Coeptis Therapeutics (NASDAQ:COEP) Lowered to Hold at LADENBURG THALM/SH SH
ETF DAILY NEWS· 2 days agoLADENBURG THALM/SH SH lowered shares of Coeptis Therapeutics (NASDAQ:COEP – Free Report) from a strong-buy rating to a hold rating in a report published on Tuesday, Zacks.com reports. Coeptis ...
Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
Zacks via Yahoo Finance· 5 days agoUpdated data from a clinical study shows that treatment with Mustang Bio's (MBIO) experimental cell...
EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer
MedPage Today· 3 days agoAstraZeneca announced that a phase III trial of capivasertib (Truqap) plus paclitaxel failed to...
Stock Market Weekly Review: Nvidia, AI Chip Plays Hit Resistance
Investor's Business Daily· 3 days agoTesla stock rose modestly. In Brief Nurix Therapeutics said Monday more than 69% of patients with...
Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike
Morningstar· 3 days agoUSA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number of cancer cases in younger age groups than before. With ...